IT'S DIFFICULT to fathom how in this protracted war against the pandemic, the virus, sars-cov-2, has managed every time to gain the upper hand over humanity, its ingenuity and its scientific breakthroughs. In the beginning, the world scrambled to decode the novel virus and its infection strategies and to churn out enough personal protection equipment, hand sanitisers, ventilators and other medical supplies. Then it was the race to develop worthy vaccines in record time. Despite humanity successfully crossing these hurdles, the novel coronavirus disease (COVID-19) continues to rage and the world now stares at yet another challenge of vaccinating everyone well in time.
Consider these numbers. Till April 8, only 711 million jabs had been administered across the world, as per the Johns Hopkins University, US. This has ensured complete inoculation of a little more than 2 per cent of the world’s adult population. According to data analytics company Airfinity, the world will manufacture 9.5 billion doses by the end of 2021. It, however, needs over 14 billion doses as soon as possible to vaccinate its entire adult population. This is almost three times the number of vaccines the world was producing in the pre-pandemic period for other diseases, as per vaccine alliance GAVI.
A worried pharmaceutical industry met on March 8 and 9 at the Global COVID-19 Vaccine Supply Chain and Manufacturing Summit in London, UK, to iron out production glitches and distribution snags in the vaccination drive. “We must urgently work together to prevent shortages from slowing the delivery of the vaccines we need in order to end the pandemic,” said Richard Hatchett, chief executive of the Coalition for Epidemic Preparedness Innovations (CEPI), a non-governmental organisation based in Oslo, Norway, at the summit.
Denne historien er fra April 16, 2021-utgaven av Down To Earth.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra April 16, 2021-utgaven av Down To Earth.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.
